Status:
UNKNOWN
Metabolomic Analysis of Exhaled Breath Condensates in Patients With COPD and Bronchiectasis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
COPD
Bronchiectasis
Eligibility:
All Genders
20+ years
Brief Summary
Metabolomics is a large-scale approach to monitoring the compounds involved in cellular processes. It may reflect changes in biological function. Collection of exhaled breath is a newly developed, non...
Detailed Description
Metabolomics is a large-scale approach to monitoring as many as possible of the compounds involved in cellular processes in a single assay to derive metabolic profiles. Compared with genomics or prote...
Eligibility Criteria
Inclusion
- patients with COPD or bronchiectasis
Exclusion
- not willing to sign ICF
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2014
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT01410422
Start Date
May 1 2011
End Date
April 1 2014
Last Update
August 5 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan